Vaginal discharge is something every woman has — it's how the vagina cleans and protects itself. But when discharge changes in color, texture, smell, or amount, it's your body signaling that something is off. The tricky part: several very different conditions can produce that signal, and getting the treatment right depends entirely on knowing which one you have.

Some causes of abnormal discharge are sexually transmitted infections (STIs) — chlamydia, gonorrhea, and trichomoniasis are the most common. Others are vaginal conditions that are not STIs — bacterial vaginosis (BV) and yeast infections are the two you'll hear most. BV and yeast can occur in women who aren't sexually active, though sexual activity can trigger or worsen them. The distinction matters because the tests, treatments, and partner-notification requirements are completely different. Treating yourself for a yeast infection when you actually have chlamydia lets an STI keep quietly damaging your reproductive tract.

~3.6M
Annual chlamydia + gonorrhea + trich cases (est.)

combined estimated US infections per year

1 in 3
BV affects US women

lifetime prevalence; most common vaginal condition ages 15–44

75%
Women who will have at least one yeast infection

lifetime incidence; half will have a second episode

How common are these conditions?. Source: CDC STI Surveillance 2023; CDC BV & Candidiasis fact sheets.
How common are these conditions?
ItemValue
Annual chlamydia + gonorrhea + trich cases (est.)~3.6M — combined estimated US infections per year
BV affects US women1 in 3 — lifetime prevalence; most common vaginal condition ages 15–44
Women who will have at least one yeast infection75% — lifetime incidence; half will have a second episode

Which STIs cause vaginal discharge?

Three STIs commonly produce vaginal discharge as a symptom. All three are bacterial or parasitic, all three are curable, and all three require a specific test to confirm. They can look different from one another — but symptoms alone are not a reliable enough guide to act on without testing.

  • Chlamydia (Chlamydia trachomatis) — the most-reported bacterial STI in the US, with about 1.65 million cases in 2023. Infects the cervix and urethra. Discharge, when it appears, is typically thin, watery, and yellowish or white. About 70% of infected women have no symptoms at all.
  • Gonorrhea (Neisseria gonorrhoeae) — over 600,000 reported cases in 2023. Discharge tends to be thicker, more yellow-green, and may be accompanied by burning with urination. About half of infected women are asymptomatic.
  • Trichomoniasis (Trichomonas vaginalis) — the most common curable non-viral STI worldwide. Discharge is typically frothy, gray-green-yellow, and carries a strong, unpleasant odor. Causes more visible symptoms than the other two, but 70–85% of infections are still asymptomatic.

What about BV and yeast infections?

BV and yeast infections are not STIs, but they're among the most common reasons women notice a change in discharge. BV is a bacterial imbalance — protective Lactobacillus bacteria are crowded out by anaerobic bacteria, raising vaginal pH. Yeast infections are fungal, almost always caused by Candida albicans overgrowing when the vaginal environment is disrupted by antibiotics, hormonal changes, or other stressors. Both are treatable, neither requires partner treatment, and neither means you have an STI.

The reason BV and yeast appear in STI discussions is that sexual activity can disturb the vaginal microbiome in ways that trigger BV, and new sexual partners increase BV risk. Trichomoniasis is genuinely an STI and is often grouped with BV in clinical discussions because both cause fishy-odor discharge — but trich requires partner treatment and BV does not. These distinctions matter when deciding what to do next.

Discharge comparison: what does each condition look like?

Chlamydia
Gonorrhea
Trichomoniasis
Bacterial Vaginosis (BV)
Yeast Infection (Candidiasis)
Vaginal discharge by condition. Source: CDC STI Treatment Guidelines 2021; ACOG Practice Bulletin.
Vaginal discharge by condition
ItemValue
Chlamydia
Gonorrhea
Trichomoniasis
Bacterial Vaginosis (BV)
Yeast Infection (Candidiasis)

Is it an STI or a vaginal condition?

This is the question that most women are actually asking when they notice something different, and it's the right one. The practical implications split cleanly into two groups.

If it's an STI (chlamydia, gonorrhea, or trichomoniasis): your sexual partners need to know and need treatment, even if they have no symptoms. Untreated STIs in partners will reinfect you. In many states, your provider can send anonymous partner notification on your behalf. You'll also need to report any recent partners and think about testing at all exposure sites — throat and rectum as well as genitals — if those routes apply to you.

If it's BV or a yeast infection: partner treatment is generally not required (though male partners of women with recurrent BV may sometimes be treated). These are not reportable conditions. Your focus is on clearing the infection, understanding what triggered it, and managing recurrence — not on contact tracing. That said, trichomoniasis is frequently mistaken for BV because both cause thin, fishy discharge; the two also co-occur. A NAAT can distinguish them definitively.

When do you need an STI test?

  • New or additional sexual partner in the past 90 days
  • Discharge that is a new color, has a new smell, or has changed in volume
  • Unprotected vaginal or anal sex
  • A partner has told you they tested positive for an STI
  • You are pregnant or planning to become pregnant
  • You are due for annual chlamydia/gonorrhea screening (all sexually active women under 25)
  • Discharge with itching that didn't respond to an OTC yeast treatment
  • Burning with urination alongside vaginal discharge
STI testing triggers — check any that apply.
STI testing triggers — check any that apply
ItemValue
New or additional sexual partner in the past 90 days→ Get tested
Discharge that is a new color, has a new smell, or has changed in volume→ Get tested
Unprotected vaginal or anal sex→ Get tested
A partner has told you they tested positive for an STI→ Get tested
You are pregnant or planning to become pregnant→ Get tested
You are due for annual chlamydia/gonorrhea screening (all sexually active women under 25)→ Get tested
Discharge with itching that didn't respond to an OTC yeast treatment→ Get tested
Burning with urination alongside vaginal discharge→ Get tested

The US Preventive Services Task Force (USPSTF) recommends annual chlamydia and gonorrhea screening for all sexually active women age 24 and younger — regardless of symptoms USPSTF, 2021. Women 25 and older who have new or multiple partners, or who live in higher-prevalence communities, should also screen annually. These recommendations exist because the majority of infections are silent, and symptoms are an unreliable alarm.

What if you have no other symptoms?

Discharge may be the only outward sign of an STI — or there may be no sign at all. This is clinically critical for chlamydia and gonorrhea, two infections where the absence of symptoms is the norm, not the exception.

About 70% of women with chlamydia report no symptoms whatsoever CDC. Approximately half of women with gonorrhea are asymptomatic. For trichomoniasis, between 70 and 85% of infected people — women and men — notice nothing. This means that a discharge so subtle you almost dismissed it could be the only clue your body offers before an untreated infection causes fallopian tube scarring, pelvic inflammatory disease (PID), or long-term infertility. Routine testing is the only reliable detection method for these infections. A doctor cannot diagnose them on clinical appearance alone.

Asymptomatic infection rates by STI (in women) (Percentage with no noticeable symptoms) Chlamydia (women): ~70%; Gonorrhea (women): ~50%; Trichomoniasis: 70–85% Chlamydia (women) ~70% Gonorrhea (women) ~50% Trichomoniasis 70–85%
Asymptomatic infection rates by STI (in women). Most women with these infections have no symptoms — which is why waiting for symptoms before testing is not a safe strategy. Source: CDC STI Treatment Guidelines 2021; CDC fact sheets.
Asymptomatic infection rates by STI (in women) (Percentage with no noticeable symptoms)
ItemPercentage with no noticeable symptoms
Chlamydia (women)~70% — approximately 70% of infected women are asymptomatic
Gonorrhea (women)~50% — roughly half of infected women have no symptoms
Trichomoniasis70–85% — most infections — in both women and men — are asymptomatic

What does normal discharge look like?

Understanding what's normal is the baseline for recognizing what isn't. Normal vaginal discharge is produced by the cervix and vaginal walls as part of healthy self-cleansing. It changes naturally across the menstrual cycle:

  • Right after your period: little to no discharge; what appears may be white or cloudy.
  • Mid-cycle (around ovulation): clear, stretchy, egg-white consistency — the most fertile window.
  • After ovulation through your next period: white or slightly yellowish, thicker, sometimes sticky or creamy.
  • Consistent throughout: no strong odor, no significant burning or itching, amount that feels familiar to you.

Warning signs that warrant evaluation: discharge that is gray, green, or yellow; discharge with a fishy or foul odor; texture that is frothy or unusually clumpy (cottage-cheese) when that's new for you; any discharge accompanied by itching, burning, or pelvic pain; or discharge that is significantly heavier or more persistent than your normal pattern. None of these automatically means an STI — but each is a reason to test rather than wait.

How is each condition diagnosed?

This is one of the most important things to understand before you test: a standard "STD panel" does not automatically include BV or yeast. These are different tests, and they're often not ordered together. Knowing what tests exist helps you ask for the right ones.

  • Chlamydia and gonorrhea: diagnosed by a nucleic acid amplification test (NAAT), the most sensitive method available. It can be done with a first-catch urine sample (no speculum needed) or a self-collected or clinician-collected vaginal swab. Results typically come back within 1–3 days. Both infections are usually tested on the same NAAT panel CDC STI Tx Guidelines, 2021.
  • Trichomoniasis: NAAT is also the preferred test and is highly accurate (>95% sensitivity). Some labs still use wet prep microscopy — looking at vaginal fluid under a microscope for the moving parasite — but NAAT catches far more cases. Trich is often not included on standard STI panels; ask specifically if you want it tested CDC STI Tx Guidelines, 2021.
  • Bacterial vaginosis: diagnosed clinically using Amsel criteria (three of four: thin discharge, clue cells on microscopy, vaginal pH >4.5, positive whiff test with KOH), or by a Gram-stain Nugent score. FDA-cleared NAAT tests are also available and increasingly used. BV is a clinical diagnosis from a pelvic exam, not a routine STI panel CDC STI Tx Guidelines, 2021.
  • Yeast infection (candidiasis): confirmed by wet prep microscopy showing budding yeast or pseudohyphae, and/or fungal culture. Vaginal pH is typically normal (<4.5) with yeast, which is a useful tiebreaker versus BV. If OTC treatment has repeatedly failed, culture is important to identify non-albicans Candida species that resist standard fluconazole CDC STI Tx Guidelines, 2021.

Treatment by condition

Treatment is condition-specific. The antibiotics that cure chlamydia will not touch a yeast infection. The antifungal that clears yeast will not affect BV. Using the wrong treatment not only fails — it can delay care long enough for an STI to cause complications, or for BV to progress during pregnancy.

  • Chlamydia: doxycycline 100 mg orally twice daily for 7 days is the preferred regimen (azithromycin 1 g single dose is an alternative). Partners must be treated concurrently CDC, 2021.
  • Gonorrhea: ceftriaxone 500 mg intramuscular single dose (or 1 g if weight is ≥150 kg). If chlamydia has not been excluded, add doxycycline. Due to increasing antibiotic resistance, gonorrhea treatment should always follow current CDC guidelines CDC, 2021.
  • Trichomoniasis: metronidazole 500 mg orally twice daily for 7 days (the multi-day regimen outperforms the older single dose in women). Partner treatment is required CDC, 2021.
  • Bacterial vaginosis: metronidazole 500 mg orally twice daily for 7 days, or metronidazole 0.75% vaginal gel once daily for 5 days, or clindamycin 2% vaginal cream nightly for 7 days. Recurrent BV (≥3 episodes/year) often needs a suppressive maintenance regimen CDC, 2021.
  • Yeast infection: a single oral dose of fluconazole 150 mg for uncomplicated cases, or intravaginal azole creams (clotrimazole, miconazole) for 3–7 days. Many topical treatments are OTC. Complicated or recurrent infections (≥4/year) require an induction course followed by weekly fluconazole maintenance CDC, 2021.

What if I'm pregnant?

All five conditions carry additional risk during pregnancy. Untreated chlamydia and gonorrhea can cause preterm birth and be passed to the newborn during delivery — a leading cause of newborn pneumonia and eye infections. Trichomoniasis is associated with preterm delivery and low birthweight. BV during pregnancy significantly raises the risk of preterm labor and premature rupture of membranes. Even yeast infections, though not dangerous to the baby, are more intense during pregnancy due to hormonal changes and require pregnancy-safe treatments (oral fluconazole is generally avoided in the first trimester). If you are pregnant and notice any abnormal discharge, get evaluated promptly — don't wait to see if it resolves.

Discharge is common — and getting tested is the right move

Abnormal vaginal discharge affects the vast majority of women at some point in their lives, across all ages, backgrounds, and relationship structures. It is one of the most common reasons for gynecology visits. Seeking testing is not an indication of risk behavior — it's routine, responsible health maintenance. Chlamydia affects roughly 1 in 20 sexually active women under 25. BV affects 1 in 3 women overall. The conditions that cause discharge are common, they're treatable, and the sooner they're identified, the simpler the treatment.

If something feels different, test — don't guess. A urine sample or vaginal swab is all it takes to distinguish a yeast infection from chlamydia, and that distinction determines whether your partner needs treatment, whether you need follow-up screening, and whether your reproductive health is at any longer-term risk. Testing is available at no cost or low cost through health departments, Planned Parenthood, Title X clinics, and many primary care providers.